Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Explore the best credit cards that come with no annual fees. Find the perfect card that suits your financial goals!
15,875 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Investing in rare earths is a long game tied to U.S. policy, global demand, and the pace of production. This guide co...
The Supreme Court decision clears a path for roughly $180 billion in tariff refunds to importers, yet Goldman Sachs c...
When rhythm pharma (rytm) releases earnings, investors get a window into revenue growth, cash health, and pipeline pr...
A fresh SEC filing shows AREX Capital Management opening a new stake in CALY with 453,000 shares worth about $5.29 mi...
Biotech giants 2026 could offer a compelling mix of growth and stability for investors. This article dives into two p...
When a notable investor sells a stake in a popular dating platform, it can raise questions about the stock’s path for...
Minnesota’s business elite issued a restrained message on immigration enforcement that drew sharp critique and raised...
Investing in today’s AI-powered era means spotting durable winners. This guide explains how to identify a meet monste...
In a bid to curb pump prices, the Trump administration announced a temporary waiver of the Jones Act. Early market re...
Many retirees are surprised to learn that part of their social security benefit can be taxed. This guide explains how...
Investors debating the better crypto buy: bitcoin face a choice between owning Bitcoin outright or stepping into a Bi...